Company Data

Trevena Inc.

Advanced Market Data

Ticker

TRVN

Current Price

$1.28

Market Cap

$1.1M

Price Target

Refer to Report

Volume

726

52wk Range

$0.95 - $11.245

Advanced Market Data

Overview

Trevena Inc is an American biotechnology company. The portfolio pipeline is focused on medicines targeting pain management: TRV734: oral medicine for moderate to severe pain; TRV250: oral medicine for migraines; and TRV027: treatment for acute heart failure. Its leading product is oliceridine (TRV130), a protein-based chemical meant to manage moderate to severe acute pain.

Other Considerations

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

Nutriband Inc.

NTRB (NSC)

$6.37

$6.3(1.11%)

71.1M

47.1K

$3.3 - $11.78

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

Unicycive Therapeutics Inc.

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc.

UNCY (NSC)

$0.6521

$0.65(0.32%)

78.1M

484.5K

$0.202 - $1.21

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

Cadrenal Therapeutics Inc.

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc.

CVKD (NSC)

$16.45

$16.5(-0.3%)

30.9M

27.8K

$5.7 - $22.9011

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

LakeShore Biopharma Co. Ltd.

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

LakeShore Biopharma Co. Ltd.

LakeShore Biopharma Co. Ltd.

LSB (NSC)

$1.19

$1.25(-4.8%)

22.7M

13.6K

$1.1501 - $11.2

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

MAIA Biotechnology Inc.

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

MAIA Biotechnology Inc.

MAIA Biotechnology Inc.

MAIA (AMX)

$2.05

$2.48(-17.34%)

60.7M

1.4M

$1.4 - $5.99

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

Baudax Bio Inc.

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

Baudax Bio Inc.

Baudax Bio Inc.

BXRX (Nasdaq)

1.7M

$0.0137 - $3.4699

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

Eledon Pharmaceuticals

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

Eledon Pharmaceuticals

Eledon Pharmaceuticals

ELDN (Nasdaq)

$3.31

$3.28(0.91%)

198.2M

96.1K

$2 - $5.54

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

Tonix Pharmaceuticals Holding Corp.

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp.

TNXP (Nasdaq)

$20

$18.04(10.86%)

128.7M

841.3K

$6.76 - $672

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

Ocugen, Inc.

OCGN (Nasdaq)

$0.765

$0.74(3.64%)

223.4M

3.9M

$0.515 - $2.06

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

PDS Biotechnology Corporation

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

PDS Biotechnology Corporation

PDS Biotechnology Corporation

PDSB (Nasdaq)

$1.38

$1.33(3.76%)

62.6M

288.8K

$0.8505 - $4.42

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data